Telix Pharmaceuticals Ltd
ASX:TLX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
AU |
|
M
|
Microsoft Corp
BMV:MSFT
|
US |
|
O
|
Orion Oyj
OTC:ORINY
|
FI |
|
Tauron Polska Energia SA
F:1T5
|
PL |
|
B
|
Believe SA
PAR:BLV
|
FR |
|
T
|
Tate & Lyle PLC
F:TLY
|
UK |
|
M
|
Medx Health Corp
OTC:MDXHF
|
CA |
|
TYMLEZ Group Ltd
ASX:TYM
|
AU |
|
C
|
China Petroleum & Chemical Corp
XBER:CHU
|
CN |
|
A
|
American Airlines Group Inc
F:A1G
|
US |
|
D
|
Deutsche Boerse AG
F:DB1
|
DE |
Wall St Price Targets
TLX Price Targets Summary
Telix Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for TLX is 24.2 AUD with a low forecast of 18.18 AUD and a high forecast of 33.6 AUD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TLX's stock price target?
Price Target
24.2
AUD
According to Wall Street analysts, the average 1-year price target for TLX is 24.2 AUD with a low forecast of 18.18 AUD and a high forecast of 33.6 AUD.
What is the Revenue forecast for Telix Pharmaceuticals Ltd?
Projected CAGR
12%
Over the last 7 years, the compound annual growth rate for Revenue has been 228%. The projected CAGR for the next 8 years is 12%.
What is the Gross Profit forecast for Telix Pharmaceuticals Ltd?
Projected CAGR
16%
The compound annual growth rate for Gross Profit over the next 8 years is 16%.
What is the Operating Income forecast for Telix Pharmaceuticals Ltd?
Projected CAGR
41%
The compound annual growth rate for Operating Income over the next 8 years is 41%.
